eMIMS New Product
Ciproxin licensed for UTI in children
23-Jun-08
The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line
treatment of complicated UTIs and pyelonephritis in children and adolescents aged between 1-17 years.
The dose is 10-20mg/kg orally every 12 hours up to a maximum of 750mg per dose. The recommended duration of treatment is 10-21 days.
Further information: Bayer plc 01635 563000
Comments
Only registered users may comment. Log in now or register for a free account.